zepbound tirzepatide injection Lilly launches lower-price weight-loss drug without injector pen Zepbound (Tirzepatide): A Q&A on

From a Brand Partner: The rise of GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro has revolutionized weight management.

Retatrutide vs Semaglutide: Evidence-based comparison of the investigational triple GIP/GLP-1/glucagon agonist versus the FDA-approved GLP-1 agonist

TROPICAL FRUITS YUMMY FIBER BOOST - A refreshing Passion fruit, Mango, Pineapple flavored Colon Broom stevia herbal drink that leaves you feeling lighter inside

A large, retrospective study conducted by scientists at The University of Texas at San Antonio suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists medications that are widely prescribed for metabolic disease have a significantly lower risk of developing colorectal cancer compared with those taking aspirin.

BMI Is GLP-1 right for me?* 24.9 or less No 25.0 29.9 Case-by-case 30.0 or above Likely *The above chart is not meant for medical diagnosis purposes

The FDA issued clarifying guidance on how and when GLP-1 meds can be compounded, and it isnt looking good for patients relying on compounds